Cetuximab (Cet) clearance and survival in patients (pts) with metastatic colorectal cancer (mCRC).
作者:
Karapetis, Christos Stelios
Karapetis, Christos Stelios
O'Callaghan, Christopher J.
O'Callaghan, Christopher J.
D O I:
10.1200/JCO.2017.35.15_suppl.3600